Delcath Systems, Inc.
NCM: DCTHLive Quote
About Delcath Systems, Inc.
Healthcare
Medical Devices
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York.
📊 Fundamental Analysis
Delcath Systems, Inc. demonstrates a profit margin of 3.2%, which is below the sector average, suggesting competitive pressure.
The company recently reported 37.3% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is 3.0%, which suggests room for improvement in capital utilization.
At a current price of $10.04, DCTH currently trades near the bottom of its 52-week range (19%), indicating potential value or weakness (Range: $8.12 - $18.23).
💰 Valuation Insight
DCTH trades at a 473.7% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$403.56M
Trailing P/E
143.43
Forward P/E
-51.22
Beta (5Y)
0.43
52W High
$18.23
52W Low
$8.12
Avg Volume
439K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App